Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.22, read 2026-10-27
Ethical does not pass the values gate
Price2.63 USD
Fair value3.55
Ethical score70.0/100
Our investment reviews on this name
2026-09-02Read Markdown4.89-46.2% to today ✓Markup gives way to Markdown after a 10% slide in 4 weeks
2026-08-03Read Markup5.42-51.5% to today Accumulation gives way to Markup after an 8% rise in 5 weeks
2026-07-02Read Accumulation5.01-47.5% to today First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
JetBlue Airways Corporation holds its Markdown at $2.63. The statistical read favours the sellers, held for 82 days.
As held on the ledger · 2026-10-23
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 82 days
Price at the screen
$2.63
Valuation
N/A trailing · -2.35 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.77
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
56.83%
Below 33%
Interest-bearing debt is 56.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
1.29%
Below 33%
Cash held in interest-bearing accounts and securities is 1.3% of assets, under the one-third limit.
Pass
Receivables
13.99%
Below 49%
Money owed to the company is 14.0% of assets, under the 49% limit.
Pass
Revenue purity
1.40%
Below 5%
Only 1.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
JetBlue Airways's business is in a permissible area, but its interest-bearing debt is about 57% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when JBLU's ethical verdict changes
Today JBLU does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 35.0% margin of safety to the base estimate.
Third-party analyst targets: 15 covering, consensus Hold. The average target sits +52% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Airlines look cheap until the next downturn hits
Picture a packed flight that suddenly empties when fuel spikes or recession fears rise. JetBlue sits in exactly that spot, posting revenue growth of just 5 percent while running an 8 percent loss and negative 34 percent return on equity. The forward multiple looks eye-catching at negative 10.1 times, yet that figure simply reflects ongoing red ink rather than any bargain.
We pass because the business shows no durable edge and the airline sector's cycles punish carriers that cannot cover their costs through the troughs. Analyst consensus sits at hold with a 6 dollar median target that matches our own modest fair value and leaves only an 11 percent margin of safety, too thin for the volatility on offer.
The low multiple is the classic cyclical trap, not a signal of value, because earnings can swing sharply lower when travel demand fades. Ethical checks clear but the financial picture does not. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
JBLU trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-27Markdown$2.65+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markdown$2.65+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$2.65+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$2.65+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$2.65-20.9%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 20.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$3.35+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$3.35+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$3.35+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$3.35-16.9%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5.
2026-10-11Markdown$4.03-11.8%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 11.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (16 analysts) rates it hold, with a mean price target of $5. Since the last review it its composite score rose.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.